Tuberculosis, a major cause of death in the nineteenth century, has consistently and steadily declined in industrialized countries. Such decline antedates the introduction of specific treatment or immunization programs. In the United States of America, the tuberculosis problem is almost exclusively confined to ethnic minorities, socially marginal groups, and migratory workers. All the countries of Latin America have adopted the programs for tuberculosis control recommended by the World Health Organization and the Pan American Health Association. The degree to which these programs are followed in Mexico is critically discussed. A number of suggestions are offered to improve a program that appears to be insufficient in terms of controlling this disease.
Get full access to this article
View all access options for this article.
References
1.
GrzybowskiS., Tuberculosis: A Look at the World Situation, Chest84: 6, pp. 756–761, 1983.
2.
PioA., Epidemiology of Tuberculosis, Minerva Medica, 75, pp. 507–517, 1984.
3.
OlveraR.LopezI. R., Evalucion del Programa de Control de la Tuberculosis en la Republica Mexicana, Salud Publica de Mexico, XXIV, 3, pp. 313–319, 1982.
4.
Instructivo del Programa Nacional de Control de la Tuberculosis, Secretaria de Salubridad y Asistencia, Mexico City, 1977.
5.
HobbyG. L.HolmanA. P.IsemanM. D., Enumeration of Tubercle Bacilli in Sputum of Patients with Pulmonary Tuberculosis, Antimicrob Agents Chemother, pp. 94–104, 1973.
6.
SniderD. E.Jr.KelleyG. D., Infection and Disease Among Contacts of Tuberculosis Cases with Drug Resistant and Drug Susceptible Bacilli, Am. Rev. Respir. Dis132, pp. 125–132, 1985.
7.
KochM. L.CoteR. A., Comparison of Fluorescence Microscopy with Ziehl-Neelsen Stain for Demonstration of Acid-Fast Bacilli in Smear Preparation and Tissue Sections, Am. Rev. Respir. Dis91: 2, pp. 283–284, 1965.
8.
NarainR. J.SubbaM. S., Microscopy Positive and Microscopy Negative Cases of Pulmonary Tuberculosis, Am. Rev. Respir. Dis103: 6, pp. 761–773, 1971.
9.
BoydJ. C.MarrJ., Decreasing Reliability of Acid Fast Smear Techniques for Detection of Tuberculosis, Ann. Intern. Med.82, pp. 489–492, 1975.
10.
HallG. H., The Clinical Application of Bayes Theorem, Lancet, 2, pp. 555–557, 1967.
11.
HooSoo G. W.PalmerD. I.SopherR. L., Reducing Tuberculosis Detection Costs, Chest, 86: 6, pp. 860–862, 1984.
12.
BenensonA. S., Control of Communicable Diseases in Man, 14th Edition, The American Public Health Association, pp. 409–416, 1983.
13.
DaviesB. H., Infectivity of Tuberculosis, Editorial, Thorax, 35, pp. 481–482, 1980.
14.
SniderD. E.Jr.AndersonH. R., Current Tuberculosis Screening Practices, Am. J. Public Health, 74: 12, pp. 1353–1356, 1984.
15.
American Thoracic Society, Guidelines for the Investigation and Management of Tuberculosis Contacts, Am. Rev. Respir. Dis114, pp. 459–463, 1976.
16.
IsemanM. D., Containment of Tuberculosis, Preventive Treatment with Isoniazid and Contact Investigation, Chest, 76: 6, pp. 801–804, 1979.
17.
HerreraM.VillegasA., Diagnostico de la Tuberculosis Pulmonar, Salud Publica de Mexico, XXIV, 3, pp. 289–293, 1982.
18.
ReichmanL. B., Tuberculin Skin Testing, The State of the Art, Chest, 76: 6, pp. 764–770, 1979.
19.
American Thoracic Society, Diagnostic Standards and Classification of Tuberculosis and Other Mycobacterial Diseases, 14th Edition, Am. Rev. Respir. Dis123: 3, pp. 343–358, 1981.
20.
RouillonA., Tuberculosis: A Model for Approaching Disease Control, Chest, 76 (Suppl.), 6, pp. 739–740, 1979.
21.
BaileyW. C.ByrdR. B., Preventive Treatment of Tuberculosis, Chest, 87 (Suppl.), 2, pp. 128–132, 1985.
22.
Barrett-ConnorsE. L.ComstockG. W., and GrzybowskiS., Committee on BCG, Chest, 87 (Suppl.), 2, pp. 133–134, 1985.
23.
American Thoracic Society, BCG Vaccines for Tuberculosis, Am. Rev. Respir. Dis112: 3, pp. 478–480, 1975.
24.
AngelJ. H., The Case for Short-Course Chemotherapy Studies of Pulmonary Tuberculosis, Drugs, 26, pp. 1–8, 1983.
25.
East African-British Medical Research Council, Controlled Clinical Trial of Four Short Course (6 Month) Regimens of Chemotherapy for Treatment of Pulmonary Tuberculosis (Second Study), Lancet, 2, pp. 1100–1106, 1974.
26.
East African-British Medical Research Council, Results at 5 Years of a Controlled Comparison of a 6 Month and a Standard 18 Regimen of Chemotherapy for Pulmonary Tuberculosis, Am. Rev. Respir. Dis116, pp. 3–8, 1977.
27.
AddingtonW. W.AlbertR., Non-Drug Issues Related to the Treatment of Tuberculosis, Chest, 87 (Suppl.), 2, pp. 125–127, 1985.
28.
East African-British Medical Research Council, Controlled Clinical Trial of Five Short Course Chemotherapy Regimens in Pulmonary Tuberculosis (Fourth Study, Second Report), Am. Rev. Respir. Dis123, pp. 165–710, 1981.
29.
FavezG.BergerL., A Controlled Trial of Individually Adapted Short Course Chemotherapy Versus Two Year Scheme in Original Treatment of Pulmonary Tuberculosis, Chest, 82: 4, pp. 426–429, 1982.
30.
Hong Kong Chest Service/British Medical Research Council, Controlled Trial of Six-Month and Eight-Month Regimens in the Treatment of Pulmonary Tuberculosis: The Results Up to 24 Months, Tubercle, 60, pp. 201–210, 1979.
31.
SheltonJ.LevyR., Behavioral Assignments and Treatment Compliance, Research Press, New York, 1981.
32.
GrossettJ., Basis for Short Course Chemotherapy, Chest, 80: 6, pp. 719–720, 1981.
33.
British Thoracic and Tuberculosis Society, Short Course Chemotherapy in Pulmonary Tuberculosis, Lancet, 2, pp. 1102–1104, 1976.
LeffD. R.LeffA. R., Tuberculosis Control Practices in Major Metropolitan Health Department in the United States, Standard of Practice, Chest, 87: 2, pp. 206–211, 1985.
36.
BuechnerH. A., Short Course Chemotherapy for Tuberculosis: A Story of Flawed Studies, Am. Rev. Respir. Dis124, pp. 655–660, 1981.
37.
BuechnerH. A., Short Course Chemotherapy for Tuberculosis: A Voice of Doubt, Ann. Intern. Med94, pp. 277–278, 1981.
38.
BuechnerH. A., Short Course Chemotherapy for Tuberculosis: Treatment of Choice?Comprehensive Therapy, 9, pp. 59–63, 1983.
39.
DutA. K.SteadW. W., Short Course Chemotherapy: The Arkansas Experience, Chest, 80: 6, pp. 724–727, 1981.
40.
East African-British Medical Research Council, Controlled Clinical Trial of Four Short Course Regimens of Chemotherapy for Two Durations in the Treatment of Pulmonary Tuberculosis (Third Study, First Report), Am. Rev. Respir. Dis118, pp. 39–47, 1978.
41.
IsemanM. D., Modern Tuberculosis Chemotherapy: Good News, Bad News (Editorial), Chest, 82: 4, pp. 396–397, 1982.
42.
National Tuberculosis in a Rural Population of South India: A Five Year Epidemiological Study, Bull. World Health Org., 51, p. 473, 1974.
